60 mcg Darbepoetin Alfa Injection

Get a Price/Quote

MOQ : 100 Packs

60 mcg Darbepoetin Alfa Injection Specification

Salt Composition
Darbepoetin Alfa 60 mcg

Dosage Form
Injection

Indication
Treatment of anemia associated with chronic renal failure or chemotherapy

Enzyme Types
Erythropoiesis-Stimulating Agent (ESA)

Feature
Ready-to-use prefilled syringe; single-use; preservative-free

Ingredients
Darbepoetin Alfa, excipients, sterile water for injection

Application
Used to stimulate erythropoiesis and increase red blood cell count

Ph Level
Approximately 6.0-7.5

Temperature Needed For Fermentation
37C (during production in bioreactors)

Physical Color/Texture
Clear, colorless aqueous solution

Fermentation Smell
Odorless (in final dosage form)

Enzymatic Activity
Stimulates erythropoietin receptor-mediated erythropoiesis

Storage Instructions
Store in a refrigerator at 2C to 8C

Shelf Life
24 months from date of manufacture

Regulatory Status
Prescription Only Medicine

Route of Administration
Intravenous (IV) or Subcutaneous (SC)

Sterility
Sterile, pyrogen-free preparation

Strength
60 mcg/0.3 ml

Packaging Type
Prefilled syringe or single-use vial

Precautions
Do not freeze; protect from light

60 mcg Darbepoetin Alfa Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 60 mcg Darbepoetin Alfa Injection

Discover rare value with 60 mcg Darbepoetin Alfa Injection, a redoubtable and noteworthy solution for anemia management related to chronic renal failure or chemotherapy. Designed for unbeatable convenience, each sterile, pyrogen-free, and preservative-free prefilled syringe or single-use vial ensures patient safety and efficacy. Administered intravenously or subcutaneously, Darbepoetin Alfa elevates erythropoiesis, boosting red blood cell production. Store under specific conditions (2C-8C, protect from light, do not freeze) to maintain optimal potency. Strictly prescription-only, this product exemplifies quality and reliability for healthcare providers and patients.

Noteworthy Application & Special Features

Used by healthcare professionals, the 60 mcg Darbepoetin Alfa Injection is ideal for chronic renal failure and chemotherapy-induced anemia. Its ready-to-use, prefilled syringe ensures precise dosage and aseptic delivery on the skin's surface or vein. Its clear, colorless composition allows quick visual inspection, while single-use, preservative-free technology reduces contamination risk, highlighting its rare reliability and user safety.

Certifications, Export Market & Shipment Details

With robust regulatory certifications, the Darbepoetin Alfa Injection is trusted in major export markets. Sample policy ensures quality transparency before shipment, while FOB port options in India facilitate secure transportation. Each unit is carefully shipped under refrigerated conditions, guaranteeing product stability from supplier to international healthcare facilities. Stringent processes ensure every export meets unbeatable quality standards for global customers.

FAQ's of 60 mcg Darbepoetin Alfa Injection:

Q: How should the 60 mcg Darbepoetin Alfa Injection be stored to ensure its effectiveness?

A: Store the injection in a refrigerator at 2C to 8C, protect it from light, and do not freeze, as these conditions preserve its sterility and potency.

Q: What is the primary usage of Darbepoetin Alfa Injection 60 mcg?

A: This injection is mainly used for treating anemia associated with chronic renal failure or chemotherapy by stimulating erythropoiesis and increasing red blood cell count.

Q: Where can the Darbepoetin Alfa Injection be administered?

A: It can be administered intravenously (IV) or subcutaneously (SC) by a healthcare professional, ensuring correct delivery and patient safety.

Q: What are the special features of the Darbepoetin Alfa 60 mcg Injection?

A: It comes in ready-to-use, preservative-free, prefilled syringes or single-use vials, is sterile and pyrogen-free, and offers a clear, colorless solution for easy inspection.

Q: When should patients expect to see a benefit from this medication?

A: Improvements in anemia symptoms generally appear within a few weeks of regular use, depending on the individual's underlying medical condition and response.

Tell us about your requirement